This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Musc Foundation for Research Development, Musc Foundation for Research Development Charleston. Active years: 2010-2019.
Company Filing History:
8 out of 178 
1 out of 1 Years Active: 2010-2019
Title: Jane Jourdan: Innovator in Medical Research
Introduction
Jane Jourdan is a prominent inventor based in Charleston, SC, known for her significant contributions to medical research. With a total of nine patents to her name, she has made remarkable strides in the field of health and medicine. Her work focuses on developing innovative solutions for treating and preventing various medical conditions.
Latest Patents
Among her latest patents are the Alpha connexin C-terminal (ACT) peptides and methods of use thereof. This patent provides compositions and methods for treating or preventing macular degeneration in subjects. Additionally, it includes methods for preserving organs and tissues for transplantation, as well as preventing cellular injury in organs or in subjects. Another notable patent involves the use of Alpha connexin C-terminal (ACT) peptides to promote wound healing and tissue regeneration following tissue injury in subjects.
Career Highlights
Jane has worked with the Medical University of South Carolina Foundation for Research Development, where she has contributed to various research initiatives. Her innovative approaches have garnered attention and respect within the medical community.
Collaborations
Throughout her career, Jane has collaborated with esteemed colleagues, including Robert G. Gourdie and Gautam Ghatnekar. These partnerships have further enhanced her research and development efforts.
Conclusion
Jane Jourdan's work exemplifies the impact of innovation in medical research. Her patents and collaborations highlight her commitment to advancing healthcare solutions. She continues to be a driving force in her field, contributing to significant advancements in medical science.